These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6814023)

  • 21. Identification of antigens of culture forms of Trypanosoma cruzi and Trypanosoma rangeli recognized by sera from patients with chronic Chagas' disease.
    Grögl M; Kuhn RE
    J Parasitol; 1984 Oct; 70(5):822-4. PubMed ID: 6439848
    [No Abstract]   [Full Text] [Related]  

  • 22. Trypanosomatid isolates from Honduras: differentiation between Trypanosoma cruzi and Trypanosoma rangeli.
    Acosta L; Romanha AJ; Cosenza H; Krettli AU
    Am J Trop Med Hyg; 1991 Jun; 44(6):676-83. PubMed ID: 1907109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Trypanosoma cruzi: induction of changes in the peripheral nervous system in different strains of mice].
    Sanz OP; Cardoni RL; Celentano AM; Rimoldi MT; Sica RE; González Cappa SM
    Rev Argent Microbiol; 1991; 23(1):30-4. PubMed ID: 1667698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface antigens of stocks and clones of Trypanosoma cruzi isolated from humans.
    Zingales B; Abuin G; Romanha AJ; Chiari E; Colli W
    Acta Trop; 1984 Mar; 41(1):5-16. PubMed ID: 6201059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variable sensitivity to complement-mediated lysis among Trypanosoma rangeli reference strains.
    de Sousa MA; Dos Santos Pereira SM; Dos Santos Faissal BN
    Parasitol Res; 2012 Feb; 110(2):599-608. PubMed ID: 21748348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A carbohydrate-containing antigen from Trypanosoma cruzi and its detection in the circulation of infected mice.
    Gottlieb M
    J Immunol; 1977 Aug; 119(2):465-70. PubMed ID: 69661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A radiometric assay for diagnosing lytic antibodies in Trypanosoma cruzi infection.
    Cardoni RL; Rottenberg ME; Segura EL
    Parasitol Res; 1988; 74(6):512-5. PubMed ID: 3143107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infectivity of Trypanosoma rangeli in a promonocytic mammalian cell line.
    Osorio Y; Travi BL; Palma GI; Saravia NG
    J Parasitol; 1995 Oct; 81(5):687-93. PubMed ID: 7472856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of cytolytic antibody in experimental Chagas' disease using a terminal radiolabelling procedure.
    Powell MR; Kuhn RE
    J Parasitol; 1980 Jun; 66(3):399-406. PubMed ID: 6771377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation between Trypanosoma cruzi and Trypanosoma rangeli using heat-shock protein 70 polymorphisms.
    Fraga J; Fernandez-Calienes A; Montalvo AM; Maes I; Dujardin JC; Van der Auwera G
    Trop Med Int Health; 2014 Feb; 19(2):195-206. PubMed ID: 24224809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanosoma cruzi: characterization of an intracellular epimastigote-like form.
    Almeida-de-Faria M; Freymüller E; Colli W; Alves MJ
    Exp Parasitol; 1999 Aug; 92(4):263-74. PubMed ID: 10425154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of natural resistance to trypanosomal infection. Role of complement in avian resistance to Trypanosoma cruzi infection.
    Kierszenbaum F; Ivanyi J; Budzko DB
    Immunology; 1976 Jan; 30(1):1-6. PubMed ID: 765264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi.
    Cestari Idos S; Evans-Osses I; Freitas JC; Inal JM; Ramirez MI
    J Infect Dis; 2008 Nov; 198(9):1276-83. PubMed ID: 18781865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
    Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
    Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of 4 immunobiochemical/molecular methods for the identification of Trypanosoma cruzi and Trypanosoma rangeli strains].
    Saldaña A; Orn A; Henriksson J; Sousa OE
    Rev Med Panama; 1993 Jan; 18(1):41-52. PubMed ID: 8475337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil.
    Steindel M; Kramer Pacheco L; Scholl D; Soares M; de Moraes MH; Eger I; Kosmann C; Sincero TC; Stoco PH; Murta SM; de Carvalho-Pinto CJ; Grisard EC
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):25-32. PubMed ID: 17889480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplification of a specific repetitive DNA sequence for Trypanosoma rangeli identification and its potential application in epidemiological investigations.
    Vargas N; Souto RP; Carranza JC; Vallejo GA; Zingales B
    Exp Parasitol; 2000 Nov; 96(3):147-59. PubMed ID: 11162365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
    Introini MV; Basso B; Moretti E
    Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES; Shikanai-Yasuda MA; Stolf AM
    J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.